48 results
IDSA Recommendations for empirical antimicrobial therapy for purulent meningitis based on patient age and specific predisposing
IDSA Recommendations ... antimicrobial therapy ... condition #IDSA ... InfectiousDiseases #Pharmacology ... #Management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... • Hepatitis B virus ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Recommendations for specific antimicrobial therapy in bacterial meningitis based on isolated pathogen and susceptibility testing.

#IDSA #Meningitis
antimicrobial therapy ... #IDSA #Meningitis ... InfectiousDiseases #Pharmacology ... #Management
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive pulmonary ... Aspergillosis #Treatment #management ... #pharmacology # ... IDSA
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... • Hepatitis A virus ... • Hepatitis B virus ... #OIs #HIVAIDS #IDSA ... #management #pharmacology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Management #Therapy
Outpatient Treatment of with Community-Acquired Pneumonia (CAP)
No comorbidities or risk factors for MRSA or Pseudomonas aeruginosa:
• Combination therapy ... fluoroquinolone #IDSA ... Treatment #Regimen #Management ... #Guidelines #pharmacology
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
RIPE Therapy - Drug ... Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #medications #pharmacology ... #IDSA #Guidelines
IDSA Treatment Recommendations for Cryptococcal Meningoencephalitis in Human Immunodeficiency Virus Infected Individuals
Induction therapy:
 • AmBd (0.7–1.0
IDSA Treatment Recommendations ... Immunodeficiency Virus ... for induction therapy ... Meningoencephalitis #IDSA ... #Treatment #management
Bronchiectasis: diagnosis and management 

Causes of localized -> diffuse bronchiectasis
Foreign body, Bronchial stenosis (tumor, .. ),
diagnosis and management ... Bacterial pneumonia, Virus ... fibrosis, Radiation therapy ... Bronchiectasis #diagnosis #management ... workup #algorithm #pulmonary